Compulsive Shopping, Sex Addiction, Dopamine, and the Side Effect No One Told You About

A short read for patients exploring treatment for depression, anxiety, or PTSD.

There is a class of medications used widely for Restless Legs Syndrome, Parkinson’s disease, and certain hormonal conditions that carries a side effect most patients are never told about: it can quietly reshape behavior. Compulsive shopping. Pathological gambling. Hypersexuality. Binge eating. Repetitive purposeless activity. The drugs are called dopamine agonists, and the behavioral side effects they cause are well-documented in the medical literature, severe in many cases, and almost entirely missed at the prescribing level.

If you are exploring treatment for depression, anxiety, or PTSD — or you are already taking medication for any of these conditions — the biology of dopamine is something worth understanding.

How dopamine drives behavior

Dopamine is one of the brain’s central signaling molecules. It governs motivation, reward learning, and the urge to repeat behaviors that feel good. When you eat something delicious, finish a difficult task, or buy something that gives you a small thrill, dopamine fires in a circuit called the mesolimbic reward pathway.

Dopamine agonist drugs — pramipexole (Mirapex), ropinirole (Requip), rotigotine (Neupro), and others — bind directly to dopamine receptors and switch that signal on. They are remarkably effective for the conditions they were designed to treat. But the same receptors that quiet a tremor or a restless leg also live in the reward circuit. When the reward circuit is over-stimulated, a meaningful fraction of patients develop what neurologists call Impulse Control Disorders (ICDs).

The estimated rate among patients on dopamine agonists is 14 to 17 percent — roughly one in six. Patients rarely connect the dots themselves. The behaviors emerge gradually. They feel like personal choices, not side effects. By the time the pattern is obvious, the financial, professional, and personal damage is often already done.

Other medications worth knowing about

Dopamine agonists are the most-studied culprit, but they are not alone. Several medications commonly used in mental health care can also drive impulsive or compulsive behavior, and patients are often taking them for years without ever having had an explicit conversation about behavioral side effects:

• Aripiprazole (Abilify) and brexpiprazole (Rexulti) — partial dopamine agonists used for depression augmentation, bipolar disorder, and schizophrenia. The FDA added a warning in 2016 about pathological gambling, compulsive shopping, hypersexuality, and binge eating with aripiprazole specifically. Most patients we meet have never been told.
• Levodopa (and carbidopa-levodopa) — the cornerstone of Parkinson’s treatment; carries a real ICD risk, especially at higher doses.
• Stimulants used for ADHD — amphetamine-class medications and methylphenidate can occasionally drive compulsive behaviors at higher doses.
• Benzodiazepines — disinhibition can surface as poor impulse control alongside the more familiar risks of dependence.
• Corticosteroids — high-dose prednisone and similar drugs can cause mood instability, impulsivity, and sometimes frank mania.

This is not a list of drugs to fear, and it is not a list of drugs to stop on your own. Every medication on it is appropriate for the right patient. The point is that behavioral side effects are real, often unmonitored, and frequently invisible to the patient until significant damage is done.

Where ketamine fits

Ketamine is mechanistically very different. Its primary action is NMDA receptor antagonism, with downstream effects on glutamate, AMPA receptors, and BDNF — the molecules involved in the regrowth of neural connections that depression and trauma can erode. It is not a dopamine agonist, and the published literature does not associate medically supervised ketamine treatment with the impulse control disorders described above.

That does not make ketamine free of considerations. It carries its own profile, including potential for psychological dependence at recreational doses, transient blood pressure changes during treatment, and dissociative experiences that need to be prepared for and integrated with care. These are exactly the kinds of risks a thoughtful clinic monitors closely.

What patients can do

A few practical steps:

• Make a list of every medication you take, with the dose and start date. Bring it to your next appointment.
• Ask the question explicitly. “Could this medication be causing me to spend, gamble, eat, or behave compulsively?”
• Tell someone you trust. Compulsive behaviors — especially online shopping — are easy to hide from yourself. A family member often spots the pattern first.
• Do not stop a medication on your own. Many of these drugs require careful tapering.
• Choose a clinic that asks about your behavior, not just your symptoms.
• The biology of medication-induced impulse control disorders is real, well-described, and identifiable when patients and clinicians know what to watch for. The cost of not knowing can be enormous — and the conversation almost never happens unless you start it.

Medical disclaimer. This article is provided for general educational purposes and does not constitute medical advice, diagnosis, or a recommendation for treatment. The medications discussed are appropriate for many patients when properly prescribed and monitored. Do not start, stop, or change any medication without consulting your prescribing physician. If you or someone you know is in a mental health crisis, contact your local emergency services or a crisis hotline immediately.

David Mahjoubi, MD
www.NutraBrainClinic.com